Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SPN-830
SPN-830
Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain
Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain
Clinical Trials Arena
Supernus
SPN-830
Parkinson's Disease
FDA
Flag link:
Working its way through a CRL on lead drug, Supernus taps $150M loan
Working its way through a CRL on lead drug, Supernus taps $150M loan
Endpoints
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Flag link:
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
Endpoints
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Flag link:
FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day
FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day
Endpoints
Supernus
FDA
SPN-812
ADHD
SPN-830
Parkinson's Disease
Flag link:
